W8AD Stock Overview
Operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$7.72 |
52 Week High | US$24.17 |
52 Week Low | US$7.47 |
Beta | 0.67 |
11 Month Change | -18.91% |
3 Month Change | -16.72% |
1 Year Change | -60.26% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -74.92% |
Recent News & Updates
Recent updates
Shareholder Returns
W8AD | GB Consumer Retailing | GB Market | |
---|---|---|---|
7D | -9.7% | 1.1% | 0.7% |
1Y | -60.3% | 12.3% | 6.1% |
Return vs Industry: W8AD underperformed the UK Consumer Retailing industry which returned 13.1% over the past year.
Return vs Market: W8AD underperformed the UK Market which returned 6.1% over the past year.
Price Volatility
W8AD volatility | |
---|---|
W8AD Average Weekly Movement | 9.3% |
Consumer Retailing Industry Average Movement | 3.1% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.4% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: W8AD's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine W8AD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1909 | 252,500 | Tim Wentworth | www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
W8AD fundamental statistics | |
---|---|
Market cap | €6.80b |
Earnings (TTM) | -€8.19b |
Revenue (TTM) | €140.10b |
0.0x
P/S Ratio-0.8x
P/E RatioIs W8AD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
W8AD income statement (TTM) | |
---|---|
Revenue | US$147.66b |
Cost of Revenue | US$121.13b |
Gross Profit | US$26.52b |
Other Expenses | US$35.16b |
Earnings | -US$8.64b |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -9.99 |
Gross Margin | 17.96% |
Net Profit Margin | -5.85% |
Debt/Equity Ratio | 78.4% |
How did W8AD perform over the long term?
See historical performance and comparisonDividends
12.1%
Current Dividend Yield-12%
Payout RatioDoes W8AD pay a reliable dividends?
See W8AD dividend history and benchmarksWalgreens Boots Alliance dividend dates | |
---|---|
Ex Dividend Date | Nov 18 2024 |
Dividend Pay Date | Dec 12 2024 |
Days until Ex dividend | 4 days |
Days until Dividend pay date | 20 days |
Does W8AD pay a reliable dividends?
See W8AD dividend history and benchmarks